Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Rejuvel 3D May Be The Best Anti-Aging Cream in the World

NUUU

In an Interview with Rejuvel Bio-Sciences Executives, Stock-Sector Explores the NASA-Licensed Science behind the Company's Breakthrough Skin Care Product, Rejuvel 3D, along with the Company's Bright Prospects

NEW YORK, NY / ACCESSWIRE / August 26, 2015 / Stock-Sector.com, an online source of news about promising medical, technology and energy companies, today announced that it is releasing an interview [VIDEO] with Charles Scimeca, President of Rejuvel Bio-Sciences, Inc (OTCQB: NUUU), and Vice President John Stickler.

In the interview, Scimeca and Stickler explain how Rejuvel has created a breakthrough skin care product using technology licensed from NASA.

Stickler describes how he traveled to Houston to learn how NASA scientists were growing stem cells-those capable of growing into any organ in the body-in a bioreactor that simulates the near weightlessness of space. In microgravity, the cells grow in three dimensions, making them far more potent than those grown in regular gravity in a flat two-dimensional dish.

Rejuvel licensed the NASA technology and then grew plant stem cells that provide the unique ingredient for their Rejuvel 3D skin cream. “It’s space certified and it will help regrow your tissue, Stickler says in the interview. “It is the best anti-aging cream in the world.” Clinical results in which wrinkles diminish, dark spots fade and skin becomes softer and more youthful prove that it works, he says.

To market the breakthrough product, Scimeca is partnering with distributors globally, and in the U.S. he intends to land a Home Shopping Channel. “We feel this product can be a home run,” he says.

That may be just the beginning for Rejuvel Bio-Sciences. “As revenues ramp up, we can move into medical type formulas and products.,” explains Scimeca.

Another strong vote of confidence in Rejuvel Bio-Sciences comes in the August 17, 2015 issue of Conservative Speculator. “I believe that its innovative products are proving they have a huge potential market,” writes Lawrence C. Oakley. “That may well result in extremely large revenue & profits.” The company, he adds, “should…provide you with a great deal of long-term appreciation, even in an unfavorable economic climate.”

For more information contact info@stock-sector.com, Stock-Sector.com, Article.

The statements contained herein may include statements of future expectations and other forward-looking statements that are based on management’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words “may”, “will”, “should,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” and similar expressions identify forward-looking statements.

Actual results, performance or events may differ materially from those in such statements due to, without limitation, (i) general economic conditions, (ii) performance of financial markets, including emerging markets, and including market volatility, liquidity and credit events (iii) the frequency and severity of insured loss events, including from natural catastrophes and including the development of loss expenses, (iv) mortality and morbidity levels and trends, (v) persistency levels, (vi) the extent of credit defaults, (vii) interest rate levels, (viii) currency exchange rates including the Euro/U.S. Dollar exchange rate, (ix) changing levels of competition, (x) changes in laws and regulations, (xi) changes in the policies of central banks and/or foreign governments, (xii) the impact of acquisitions, including related integration issues, (xiii) reorganization measures, and (xiv) general competitive factors, in each case on a local, regional, national and/or global basis.

SOURCE: Stock-Sector.com



Related News